Nosa Med AB (NOSA) - Total Assets
Based on the latest financial reports, Nosa Med AB (NOSA) holds total assets worth Skr67.06 Million SEK (≈ $7.22 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See NOSA net asset value for net asset value and shareholders' equity analysis.
Nosa Med AB - Total Assets Trend (2016–2024)
This chart illustrates how Nosa Med AB's total assets have evolved over time, based on quarterly financial data.
Nosa Med AB - Asset Composition Analysis
Current Asset Composition (December 2024)
Nosa Med AB's total assets of Skr67.06 Million consist of 61.2% current assets and 38.8% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 20.9% |
| Accounts Receivable | Skr3.77 Million | 18.2% |
| Inventory | Skr4.13 Million | 20.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr1.39 Million | 6.7% |
| Goodwill | Skr0.00 | 0.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Nosa Med AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see NOSA market cap overview.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Nosa Med AB's current assets represent 61.2% of total assets in 2024, an increase from 25.0% in 2016.
- Cash Position: Cash and equivalents constituted 20.9% of total assets in 2024, down from 24.2% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, a decrease from 60.0% in 2016.
- Asset Diversification: The largest asset category is inventory at 20.0% of total assets.
Nosa Med AB Competitors by Total Assets
Key competitors of Nosa Med AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Demant A/S
CO:DEMANT
|
Denmark | Dkr39.07 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Beijing Wandong Medical Technology Co Ltd
SHG:600055
|
China | CN¥5.70 Billion |
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
MODULIGHT OY EO 1
F:78W
|
Germany | €49.14 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €57.17 Million |
|
Theradiag SA
PA:ALTHE
|
France | €11.55 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
Australia | AU$23.67 Million |
Nosa Med AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.40 | 4.26 | 2.59 |
| Quick Ratio | 1.97 | 3.54 | 2.59 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr16.67 Million | Skr12.63 Million | Skr20.89 Million |
Nosa Med AB - Advanced Valuation Insights
This section examines the relationship between Nosa Med AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.88 |
| Latest Market Cap to Assets Ratio | 0.83 |
| Asset Growth Rate (YoY) | -37.4% |
| Total Assets | Skr20.70 Million |
| Market Capitalization | $17.28 Million USD |
Valuation Analysis
Near Book Valuation: The market values Nosa Med AB's assets close to their book value (0.83x), suggesting investors view the company's assets at approximately fair value.
Significant Asset Reduction: Nosa Med AB's assets decreased by 37.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Nosa Med AB (2016–2024)
The table below shows the annual total assets of Nosa Med AB from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Skr20.70 Million ≈ $2.23 Million |
-37.44% |
| 2023-12-31 | Skr33.08 Million ≈ $3.56 Million |
+52.67% |
| 2022-12-31 | Skr21.67 Million ≈ $2.33 Million |
-45.95% |
| 2021-12-31 | Skr40.09 Million ≈ $4.31 Million |
-65.52% |
| 2020-12-31 | Skr116.25 Million ≈ $12.51 Million |
-42.91% |
| 2019-12-31 | Skr203.64 Million ≈ $21.92 Million |
-5.10% |
| 2018-12-31 | Skr214.60 Million ≈ $23.09 Million |
+7.45% |
| 2017-12-31 | Skr199.72 Million ≈ $21.49 Million |
+16.34% |
| 2016-12-31 | Skr171.66 Million ≈ $18.47 Million |
-- |
About Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more